State Street Corp Maintains Passive Stake in Pfizer Inc.
Ticker: PFE · Form: SC 13G/A · Filed: Jan 29, 2024 · CIK: 78003
| Field | Detail |
|---|---|
| Company | Pfizer Inc (PFE) |
| Form Type | SC 13G/A |
| Filed Date | Jan 29, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amended-filing, passive-investment
TL;DR
**State Street still owns Pfizer stock, showing big-money confidence.**
AI Summary
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 29, 2024, disclosing its ownership of Pfizer Inc. common stock as of December 31, 2023. This filing indicates that State Street continues to hold a significant, though passive, stake in Pfizer, a pharmaceutical giant. This matters to investors because State Street's continued holding signals confidence in Pfizer's long-term prospects, as large institutional investors typically conduct extensive due diligence.
Why It Matters
This filing confirms State Street Corporation's ongoing, passive investment in Pfizer, signaling institutional confidence in the pharmaceutical company's stability and future outlook.
Risk Assessment
Risk Level: low — This filing is routine and indicates a passive investment by a large institution, posing minimal risk to current or prospective investors.
Analyst Insight
Investors should view this as a routine disclosure of an institutional holding. While it doesn't suggest immediate action, it reinforces that major institutions like State Street continue to hold Pfizer stock, which can be a positive long-term signal.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- Pfizer Inc. (company) — the subject company whose common stock is being reported
- 04-2456637 (number) — State Street Corporation's IRS Identification No.
- 717081103 (number) — the CUSIP number for Pfizer Inc. Common Stock
- December 31, 2023 (date) — the date of the event requiring the filing
- January 29, 2024 (date) — the filing date of the SC 13G/A
FAQ
What type of filing is this document and what does it signify?
This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It signifies that State Street Corporation is updating its previous disclosure regarding its beneficial ownership of Pfizer Inc. common stock, as required by Rule 13d-1(b) of the Securities Exchange Act of 1934.
Who is the 'Reporting Person' in this filing?
The 'Reporting Person' is STATE STREET CORPORATION, identified with IRS Identification No. 04-2456637, located at 1 Congress Street, Boston, MA 02114.
What is the 'Subject Company' and its CUSIP number?
The 'Subject Company' is PFIZER INC., a pharmaceutical preparations company with a Central Index Key (CIK) of 0000078003. The CUSIP number for its Common Stock is 717081103.
What was the 'Date of Event Which Requires Filing of This Statement'?
The 'Date of Event Which Requires Filing of This Statement' was December 31, 2023, indicating the ownership position being reported is as of the end of the last fiscal year.
Under which specific rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b) of the Securities Exchange Act of 1934, as indicated by the 'X' in the appropriate box on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 29, 2024 regarding PFIZER INC (PFE).